Hannah R. Rosenblum, MD
Cardiovascular Disease
Accepting New Patients
Virtual Visits/Telehealth
Overview
Dr. Rosenblum received her Medical Degree from New York University School of Medicine. She completed her internship, medical residency, fellowship in cardiovascular medicine, and fellowship in advanced heart failure at Columbia University Irving Medical Center.
Dr. Rosenblum is an Assistant Professor of Medicine at Columbia University Irving Medical Center. Her areas of expertise include consultative cardiology, critical care cardiology, heart failure and women’s heart health. Dr. Rosenblum is board certified in cardiology and echocardiography, and board eligible in advanced heart failure.
Dr. Rosenblum’s research is focused on heart failure with preserved ejection fraction, cardiac amyloidosis, cardiac hemodynamics, and critical care cardiology. Her research has been published in prestigious, peer-reviewed journals, including Circulation, Circulation - Heart Failure, and the Journal of American College of Cardiology.
Areas of Expertise / Conditions Treated
- Cardiology
- Critical Care Cardiology
- General Cardiology
- Womens Heart Disease
Academic Appointments
- Assistant Professor of Medicine at CUMC
Gender
- Female
Schedule an Appointment
Virtual Visits/Telehealth
Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Aetna
- Aetna Signature Administrators
- NY Signature
- Student Health
Affinity Health Plan
- Medicaid Managed Care
AgeWell
- Medicare Managed Care
- Special Needs
Amerigroup of New Jersey
- New Jersey Services (Medicaid Managed Care)
Cigna
- EPO
- Great West (National)
- HMO
- Medicare Managed Care
- POS
- PPO
Emblem/GHI
- Medicare Managed Care
- PPO
Emblem/HIP
- ConnectiCare
- EPO
- Essential Plan
- HMO
- Medicare Managed Care
- POS
- PPO
- Select Care (Exchange)
- Vytra
Empire Blue Cross Blue Shield HealthPlus
- Child/Family Health Plus
- Essential Plan
Fidelis Care
- Essential Plan
- Medicaid Managed Care
- Medicare Managed Care
Healthfirst
- Child/Family Health Plus
- Leaf (Exchange)
- Medicare Managed Care
Local 1199
- Local 1199
- NYP Employee Plan
MagnaCare (National)
- MagnaCare
Medicare
- Railroad
- Traditional Medicare
Multiplan
- Multiplan
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- HMO
- Medicaid Managed Care
Quality Health Management
- Quality Health Management
RiverSpring
- Special Needs
UnitedHealthcare
- Compass (Exchange)
- Empire Plan
- HMO
- Medicaid (Community Plan)
- Oxford Freedom
- Oxford HMO
- Oxford Liberty
- POS
- PPO
WellCare
- Medicare Managed Care
World Trade Center Health Plan
- World Trade Center Health Plan
*Please contact the provider’s office directly to verify that your particular insurance is accepted.
Credentials & Experience
Honors & Awards
- Loan Repayment Program Award; NIH NHLBI, 2020-2024
- Glorney Raisbeck Fellowship Award in Cardiovascular Diseases; New York Academy of Medicine, 2020-2021
- T32 HL007854 Postdoctoral Training in Cardiovascular Disease; NYP/CUMC, 2018-2020
- Milton B. Rosenbluth Scholar for International Health; NYU School of Medicine, 2015
- Glorney-Raisbeck Medical Student Grant in Cardiovascular Research; New York Academy of Medicine, 2012
- Student Scholarship in Cardiovascular Disease; American Heart Association, 2012
- Angell B. Scholar; University of Michigan, 2011
Research
Selected Publications
- Rosenblum H, Haythe JH, Lau ES.
The fall of Roe: the devastating Impact of the Dobbs vs Jackson Decision on Women Living with Heart Failure
J Cardiac Failure. 2023 Aug;29(8):1207-1209.
- Maurer MS, Rosenblum HR.
Difficult Diagnosis Are Often Undertreated: The Case of HFpEF with Exercise Induced Left Atrial Hypertension
JACC Heart Failure. 2023 Aug;11(8 Pt 2):1118-1120.
- Rosenblum H, Griffin J, Minamisawa M, Prasad N, Vest J, White M, Solomon S, Burkhoff D, Maurer MS.
Effect of patisiran on stroke volume in hereditary transthyretin-mediated amyloidosis: insights from pressure-volume analysis of the APOLLO study.
- Kennel PJ, Rosenblum H, Axsom KM, Alishetti S, Brener M, Horn E, Kirtane A, Lin E, Griffin JM, Maurer MS, Burkhoff D, Sayer G, Uriel N.
Remote cardiac monitoring in heart failure: a review
JAMA Cardiol. 2022 May 1;7(5):556-564.
- Griffin JM, Rosenblum H, Maurer MS.
Pathophysiology and therapeutic approach to cardiac amyloidosis.
Circulation Research. 2021 May 14;128(10):1554-1575
- Rosenblum H, Burkhoff D, Maurer MS.
Untangling the physiology of transthyretin cardiac amyloidosis by leveraging echocardiographically derived pressure volume indices.
Eur Heart J. 2020 Apr 7;41(14):1448-1450.
- Rosenblum H, Masri A, Narotsky DL, Goldsmith J, Hamid N, Hahn RT, Kodali S, Vahl T, Nazif T, Khalique OK, Bokhari S, Soman P, Cavalcante JL, Maurer MS, Castaño A.
Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis.
Eur J Heart Fail. 2021 Feb;23(2):250-258
- Rosenblum H, Kapur NK, Abraham WT, Udelson J, Itkin M, Uriel N, Voors AA, Burkhoff D.
Conceptual considerations for device-based therapy in acute decompensated heart failure: DRI2P2S.
Circ Heart Fail. 2020 Apr;13(4):e006731
- Rosenblum H, Burkhoff D, Maurer MS.
Untangling the physiology of transthyretin cardiac amyloidosis by leveraging echocardiographically derived pressure volume indices.
Eur Heart J. 2020 Apr 7;41(14):1448-1450.
- Rosenblum H, Hamid N, Narotsky N, Hahn R, Kodali S, Nazif T, Khalique O, Bokhari S, Maurer M, Castano A.
Beyond the valve and into the muscle: a review of coexisting aortic stenosis and transthyretin cardiac amyloidosis
- Rosenblum H, Castano A, Alvarez J, Helmke S, Maurer MS.
TTR stabilizers are associated with improved survival in patients with transthyretin cardiac amyloidosis.
Circulation: Heart Failure. 2018 April; 11(4).
- Hummel S, Seymour E, Brook R, Kolias T, Sheth S, Rosenblum H, Wells J, Weder A.
Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction.
Hypertension. 2012 Nov;60(5):1200-6.
- Rosenblum H, Helmke S, Williams P, Teruya S, Jones M, Burkhoff D, Mancini D, Maurer M.
Peak cardiac power measured noninvasively with a bioreactance technique is a predictor of adverse outcomes in patients with advanced heart failure.
Congestive Heart Failure. 2010 Nov-Dec;16(6):254-8.